Showing results (731-740 of 1,410) with videos related to

Sort By:
Pageof 141
NPJ Parkinson'S Disease|March 17, 2022
Altered expression of the immunoregulatory ligand-receptor pair CD200-CD200R1 in the brain of Parkinson's disease patientsNeus Rabaneda-Lombarte, José Manuel Vidal-Taboada, Tony Valente, et al.
NPJ Parkinson'S Disease|March 26, 2022
Comparative efficacy of surgical approaches to disease modification in Parkinson diseaseShervin Rahimpour, Su-Chun Zhang, Jerrold L Vitek, et al.
NPJ Parkinson'S Disease|October 11, 2018
Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the ratL Anselmi, C Bove, F H Coleman, et al.
NPJ Parkinson'S Disease|March 8, 2022
Short-term effect of dopaminergic medication on speech in early-stage Parkinson's diseaseTereza Tykalova, Michal Novotny, Evzen Ruzicka, et al.
NPJ Parkinson'S Disease|March 19, 2022
The emerging postural instability phenotype in idiopathic Parkinson diseaseFrank M Skidmore, William S Monroe, Christopher P Hurt, et al.
NPJ Parkinson'S Disease|June 27, 2017
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?M A Qamar, A Sauerbier, M Politis, et al.
NPJ Parkinson'S Disease|June 27, 2017
Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson's diseaseReinhard Stöger, Paula J Scaife, Freya Shephard, et al.
NPJ Parkinson'S Disease|June 27, 2017
Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analysesFranziska Albrecht, Sandrine Bisenius, Rodrigo Morales Schaack, et al.
NPJ Parkinson'S Disease|April 13, 2018
Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's diseaseDavid Sulzer, Clifford Cassidy, Guillermo Horga, et al.
NPJ Parkinson'S Disease|July 14, 2018
Prevalence of Parkinson's disease across North AmericaC Marras, J C Beck, J H Bower, et al.
Pageof 141